This inventor holds 3 USPTO granted patents. Top assignees: Rula Zain-Luqman, Other. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Täby, SE (2016 - 2019)
- Taby, SE (2022)
Company Filing History:
1 out of 1 
2 out of 834,513 Years Active: 2016-2022
Title: Rula Zain-Luqman: Innovator in Genetic Therapeutics
Introduction
Rula Zain-Luqman is a prominent inventor based in Täby, Sweden. She has made significant contributions to the field of genetic therapeutics, particularly in the diagnosis and treatment of neurodegenerative diseases. With a total of 3 patents, her work focuses on innovative methods that target specific genetic sequences to combat serious health conditions.
Latest Patents
One of her latest patents is a therapeutic method for Huntington's disease. This invention involves anti-gene oligonucleotides designed to hybridize to DNA in the HTT gene. These oligonucleotides are based on locked nucleic acids and phosphorodiamidate morpholino oligomers. They aim to down-regulate the expression of the HTT gene, leading to reduced HTT mRNA and protein levels in affected individuals. The invention also includes a delivery system for these oligonucleotides, which can be used in the diagnosis, treatment, and prevention of Huntington's disease.
Another significant patent addresses the diagnosis and treatment of Friedreich's ataxia. This invention utilizes oligonucleotides based on peptide nucleic acid or equivalent analogs. These oligonucleotides are designed to dissociate higher-order structures in DNA, which can be crucial for diagnosing and treating Friedreich's ataxia. The method emphasizes the use of specific sequences to enhance the effectiveness of the treatment.
Career Highlights
Rula Zain-Luqman has worked with various organizations throughout her career. Her experience has allowed her to develop groundbreaking technologies that have the potential to change the landscape of genetic medicine.
Collaborations
Throughout her career, Rula has collaborated with notable individuals such as Liam Good and Helen Bergquist. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Rula Zain-Luqman's work exemplifies the impact of innovation in the field of genetic therapeutics. Her patents reflect a commitment to advancing medical science and improving patient outcomes. Her contributions are paving the way for future breakthroughs in the treatment of genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile